Search
Powered By HealthLine
Special Offers
Health Tools
 Depression Basics
 Antidepressant Drug Info
 Depression Q&A
 Depression Support Groups
 Depression Related Disorders
Featured Conditions
 Depression
 Anxiety
 Sleep
 Bipolar
Resources
Healthscout News
3D Health Animations
Health Videos
Quizzes & Tools
Health Encyclopedia
Library & Communities
News Archive
Drug Library
Find a Therapist
Enter City or Zip Code:
Powered by Psychology Today



Channels
Home |  Today | Women| Men| Kids| Seniors| Diseases| Addictions| Sex & Relationships| Diet, Fitness, Looks| Alternative Medicine| Drug Checker
Drug DescriptionSide Effects & Drug InteractionsWarnings & Precautions
Clinical PharmacologyOverdosage & ContraindicationsIndications & DosagePatient Info

Valtrex

[Valacyclovir]

Herpes zoster 1 gram every 8 hours 1 gram every 12 hours 1 gram every 24 hours 500 mg every 24 hours

Genital herpes
Initial treatment

1 gram every 12 hours no reduction 1 gram every 24 hours 500 mg every 24 hours

Text Continues Below



Genital herpes
Recurrent episodes
500 mg every 12 hours no reduction 500 mg every 24 hours 500 mg every 24 hours

Genital herpes
Suppressive therapy
1 gram every 24 hours no reduction 500 mg every 24 hours 500 mg every 24 hours 500 mg every 24 hours no reduction 500 mg every 48 hours 500 mg every 48 hours

Genital herpes
Suppressive therapy in HIV-infected patients
500 mg every 12 hours no reduction 500 mg every 24 hours 500 mg every 24 hours

Herpes labialis (cold sores)
Do not exceed 1 day of treatment.
Two 2-gram doses taken about 12 hours apart

Two 1-gram doses taken about 12 hours apart

Two 500-mg doses taken about 12 hours apart

500-mg
single dose

Hemodialysis

During hemodialysis, the half-life of acyclovir after administration of VALTREX is approximately 4 hours. About one third of acyclovir in the body is removed by dialysis during a 4-hour hemodialysis session. Patients requiring hemodialysis should receive the recommended dose of VALTREX after hemodialysis.

Peritoneal Dialysis

There is no information specific to administration of VALTREX in patients receiving peritoneal dialysis. The effect of chronic ambulatory peritoneal dialysis (CAPD) and continuous arteriovenous hemofiltration/dialysis (CAVHD) on acyclovir pharmacokinetics has been studied. The removal of acyclovir after CAPD and CAVHD is less pronounced than with hemodialysis, and the pharmacokinetic parameters closely resemble those observed in patients with ESRD not receiving hemodialysis. Therefore, supplemental doses of VALTREX should not be required following CAPD or CAVHD.

HOW SUPPLIED

VALTREX Caplets (blue, film-coated, capsule-shaped tablets) containing valacyclovir hydrochloride equivalent to 500 mg valacyclovir and printed with "VALTREX 500 mg."

Bottle of 30 (NDC 0173-0933-08) and unit dose pack of 100 (NDC 0173-0933-56). VALTREX Caplets (blue, film-coated, capsule-shaped tablets) containing valacyclovir hydrochloride equivalent to 1 gram valacyclovir and printed with "VALTREX 1 gram." Bottle of 21 (NDC 0173-0565-02). Store at 15° to 25°C (59° to 77°F).

GlaxoSmithKline
Research Triangle Park, NC 27709

©2003, GlaxoSmithKline. All rights reserved.
August 2003 RL-2037

Page:  << Prev | 1 | 2 | 3








We comply with the HONcode standard for trustworthy health
information:
verify here.
About The HealthScout Network Contact Us
Copyright © 2001-2008. The HealthCentralNetwork, Inc. All rights reserved.
Privacy Policy  Terms of Service